democrat raise concern health secretary nominee bought sold health related stock influential voice healthcare policythis article 3 year oldthis article 3 year olddonald trump choice health secretary tom price face first congressional grilling wednesday hour leading democrat called investigation congressman investment price bought sold health related stock influential voice healthcare policy house representative advocating bill affected health company fortune made trade actively sponsoring co sponsoring voting dozen bill could affect company wrote senator elizabeth warren letter price hearing wednesday perplexing decision actively trade health stock writing policy could affect raise serious question potential conflict interest judgment warren two senator committee also called price hearing delayed question ethical qualification resolved another leading democrat senator chuck schumer called investigation purchase stock medical device company said cry investigation wednesday hearing determine price ultimate eligibility health secretary job left senate finance committee 24 january but first hearing likely raise host uncomfortable question health stock tradesprice traded 300 000 worth stock 40 health related company since 2012 according analysis wall street journal among trade large company pfizer bristol myers squibb insurer aetna notable stock purchase little known australian company innate immunotherapeutics august 2016 bought 50 000 100 000 worth stock discount company innate hold patent approved drug one drug development mis416 the company hope drug treat advanced form multiple sclerosis progressive nervous system disorder the treatment second phase clinical trial drug tested placebo effectiveness trump transition spokesman told wall street journal price complied fully applicable law ethic rule innate immunotherapeutics investor also tie trump transition team the company largest investor republican chris collins trump congressional liaison he worked closely price past helped shape health legislation other investor company collins two adult child collins chief staff michael hook former congressman turned lobbyist represented collins district bill paxon according new york time price would bought innate share 25 34 australian cent 19 26 cent bought 50 000 100 000 worth stock according innate immunotherapeutics document congressional disclosure form since value stock ballooned 1 30 letter security exchange commission office congressional ethic advocacy group public citizen said available information far fall short evidence illegal insider trading violation congressional ethic rule occurred pattern opportunity remarkable financial benefit gained gained warrant investigation hip billprice also bought stock medical device company le week introducing legislation would postponed move would cost company money price sponsored hip act march six day buying 15 000 stock zimmer biomet leading producer joint replacement device according congressional financial disclosure price legislation would delayed medicare reform called affordable care act put pressure hospital thus supplier reduce cost care though price bill died committee zimmer made donation price political action committee bill introduced november 2015 june 2016 price aide told cnn first reported story price account managed broker aware transaction